Michelle Fortney, APRN
Psychiatric/Mental Health, Adult · Bismarck, NDNPI 1174858468
Payments from drug & device makers
Across 50 payments — averaging $19.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$222
- AbbVie$205
- Axsome Therapeutics, Inc.$141
- Sunovion Pharmaceuticals Inc.$110
- Alkermes, Inc.$87
- Lundbeck LLC$72
- plus $140 from 5 others
What the payments were for
- Food & beverage$977100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $222 |
| AbbVie | 10 | $205 |
| Axsome Therapeutics, Inc. | 3 | $141 |
| Sunovion Pharmaceuticals Inc. | 11 | $110 |
| Alkermes, Inc. | 5 | $87 |
| Lundbeck LLC | 4 | $72 |
| Otsuka America Pharmaceutical, Inc. | 4 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
| Vanda Pharmaceuticals Inc. | 1 | $13 |
| Eisai Inc. | 1 | $12 |
How this compares
Too few psychiatric/mental health, adult providers in North Dakotato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ZoloftSertraline Hcl | 11 | $7,432 |
| Escitalopram Oxalate | 61 | $828 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 12 | $603 |
| Bupropion XlBupropion Hcl | 50 | $394 |
| Duloxetine Hcl | 29 | $308 |
| Sertraline Hcl | 37 | $281 |
| Clonazepam | 52 | $223 |
| Quetiapine Fumarate | 18 | $178 |
| Nortriptyline Hcl | 13 | $93 |
| Fluoxetine Hcl | 11 | $42 |
| Lorazepam | 14 | $40 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health, adult in Bismarck
- Susan DuganMinot$23
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.